scispace - formally typeset
Search or ask a question

What techniques can be used to characterise the effect of interleukin from macrophage? 


Best insight from top research papers

Interleukin (IL) effects on macrophages can be characterized using several techniques. One approach is to evaluate the production of IL1 by monocytes in the presence of different biomedical polymers, which can be used as a model system for studying macrophage activation . Another technique involves investigating the impact of IL-4 on nitric oxide (NO) production by macrophages. This can be done by priming macrophages with IL-4 and then stimulating them with interferon-gamma (IFN-γ) and/or lipopolysaccharide (LPS) to measure NO2 accumulation . Additionally, IL-4 has been shown to induce apoptosis of acute myeloid leukemia (AML) cells in a Stat6-dependent manner, and IL-4-induced macrophages have been characterized using RNA sequencing and gene expression analysis . IL-10 has also been studied for its effect on NO production by macrophages, with differential responses observed depending on the macrophage population . Overall, these techniques provide insights into the role of ILs in modulating macrophage function and can help in understanding their therapeutic potential in various diseases.

Answers from top 5 papers

More filters
Papers (5)Insight
The techniques used in this study to characterize the effect of interleukin on macrophages included measuring nitric oxide production and tumor necrosis factor-alpha levels.
The paper does not mention specific techniques used to characterize the effect of interleukin-6 on macrophages.
Flow cytometry can be used to characterize the effect of interleukin from macrophages.
Flow cytometry analysis and RNA sequencing can be used to characterize the effect of interleukin on macrophages.
In vitro cell culture techniques can be used to evaluate the effect of interleukin from macrophages.

Related Questions

How myosin help in macrophage polaerization?4 answersMyosin plays a crucial role in macrophage polarization by contributing to intercellular adhesion and phagocytosis processes. Specifically, class 1 myosins, such as myosin 1f, are involved in enhancing intercellular adhesion properties during inflammation, leading to the acquisition of a proinflammatory M1-like phenotype in macrophages. Additionally, myosin 1f is essential for efficient phagocytosis of antibody-opsonized targets, as it helps in coordinating adhesion turnover during this process. Furthermore, myosin XVIIIA, a low-abundance form of myosin, is tyrosine-phosphorylated after activation of the CSF-1 receptor, potentially influencing its cellular localization and interactions with other proteins, which could impact macrophage differentiation. Overall, myosins contribute significantly to macrophage function by regulating adhesion, phagocytosis, and potentially differentiation processes.
What is the specific marker of macrophage?5 answersThe specific marker of macrophages identified in the research includes FCER1G and TYROBP, validated as strong universal biomarkers for macrophages in human and mouse tissues. Additionally, the biomarker panel for tumor-associated macrophages consists of CD163, MS4A4A, MS4A6A, S100A4, DAB2, and LIPA, enabling prognosis prediction and therapeutic agent discovery in cancer. Furthermore, CTSZ has been found to be expressed specifically in macrophages in clear cell renal cell carcinoma, indicating its role as a marker for these immune cells. These markers play crucial roles in identifying and studying macrophages in various tissues and pathological conditions, highlighting their significance in immunology research.
What are the effects of macrophage activation on lymphocytes?5 answersMacrophage activation can have various effects on lymphocytes. Activated lymphocytes have been shown to interfere with the differentiation of macrophages, suppressing their maturation process. This suppression of macrophage differentiation can be induced by small numbers of activated lymphocytes and can be transmitted by soluble factors or through cell-cell contact, depending on the mode of lymphocyte stimulation. Additionally, macrophages and macrophage products have been found to stimulate responses of T and B lymphocytes in vitro, but when present in high numbers, macrophages can inhibit immune responses of lymphocytes. These inhibitory effects of macrophages are non-specific and can affect various T and B lymphocyte responses to antigens and mitogens. Overall, the effects of macrophage activation on lymphocytes involve both suppression of macrophage differentiation and modulation of lymphocyte immune responses.
How does the M1 macrophage affects the MSCs?5 answersM1 macrophages have been shown to affect mesenchymal stem cells (MSCs) in several ways. In the myocardial infarction microenvironment, M1-type macrophage-derived exosomes induce apoptosis in MSCs by delivering miR-222 to them. M1 macrophages also promote the osteogenic differentiation of bone marrow MSCs (BMMSCs) better than M0 macrophages, and exosomes derived from M1 macrophages enhance the osteogenic capacity of BMMSCs by activating Akt and increasing RUNX2 levels. However, in the hypoxic environment typically observed in chronic wounds, hypoxia inhibits MSC-induced M1 to M2 macrophage transition, suggesting that hypoxic environments may impede the therapeutic effects of MSCs. Additionally, co-culture of MSCs with M2 macrophages, but not with M1 or M0 macrophages, results in increased MSC mineralization, indicating that M2 macrophages promote the osteogenic differentiation of MSCs. Overall, M1 macrophages can affect MSCs by inducing apoptosis, promoting osteogenic differentiation, and influencing macrophage polarization.
How is macrophage polarization measured?5 answersMacrophage polarization can be measured using various methods. One approach is to examine the metabolic switch of macrophages by measuring oxidative phosphorylation and glycolysis. Another method involves utilizing AFM-based infrared spectroscopy (AFM-IR) to investigate the influence of inducers on the expressed proteins of M1/M2 macrophages. Changes in surface markers, transcripts, or functions are often used to characterize polarization. Additionally, deep transcriptomic profiling can be performed to analyze the global transcriptomic profiles of macrophages during polarization. Tracking changes in cell surface antigens, gene expression, and cell signaling pathways can also provide insights into macrophage polarization.
What is IM macrophage?5 answersIM macrophage refers to an immuno-magnetosome developed by coating a leukocyte membrane on a magnetic nanocluster. This biomimetic IMS exhibits good stability, magnetic controllability, and satisfactory binding avidity to circulating tumor cells while maintaining stealth properties to leukocytes.

See what other people are reading

How does the regulation of enolase2 expression affect cellular processes and overall health?
5 answers
Regulation of enolase 2 (ENO2) expression impacts various cellular processes and health outcomes. ENO2 overexpression is associated with worsened prognosis in papillary renal cell carcinoma (pRCC) and is linked to increased glycolysis. In acute lymphoblastic leukemia (ALL), ENO2 promotes cell growth, glycolysis, and glucocorticoid resistance, affecting chemotherapeutic efficacy and relapse monitoring. In head and neck squamous cell carcinoma (HNSCC), ENO2 is crucial for cell proliferation and glycolysis by controlling PKM2 stability and nuclear translocation, influencing glycolytic flux and cell cycle progression. Additionally, ENO2 overexpression in clear cell renal carcinoma (ccRCC) correlates with worse clinical features and prognosis, affecting immune infiltration and therapy sensitivity. These findings highlight ENO2 as a potential therapeutic target for cancer treatment, emphasizing its role in modulating cellular processes and health outcomes.
What is the latest research on umbilical cord blood stem cells in 2023?
5 answers
The latest research on umbilical cord blood stem cells in 2023 highlights their significant potential in regenerative medicine and disease treatment. Umbilical cord stem cells, including mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC), have shown promise in differentiating into various cell types, such as chondrocytes, osteocytes, and myocytes, with immunosuppressive properties that can aid in preventing rejection post-transplantation. Moreover, cord blood transplantation (CBT) has emerged as a successful alternative for hematopoietic stem cell transplants, offering advantages like lower risk of chronic graft-versus-host disease and extended access to adults due to less stringent HLA matching requirements. Research is also focusing on utilizing umbilical cord blood stem cells for conditions like hypoxic-ischemic encephalopathy (HIE) and cerebral palsy, showcasing the potential for innovative treatments in the field of regenerative medicine.
How to increase single cell colony formation in serum free media?
5 answers
To enhance single cell colony formation in serum-free media, various strategies can be employed based on the research findings. Adding ornithine or a combination of ornithine and putrescine to serum-free media can improve viable cell density and increase the production of a protein of interest. Additionally, the use of a serum-free quality and quantity control culture system containing specific growth factors like stem cell factor, thrombopoietin, vascular endothelial growth factor, interleukin-6, and Flt-3 ligand has been shown to significantly increase colony-forming endothelial progenitor cells (EPCs) in vitro, leading to enhanced regenerative potential. Moreover, the presence of bone morphogenetic protein 9 (BMP-9) in serum-free liquid cultures has been found to regulate the proliferation of primitive hematopoietic progenitor cells, demonstrating a dual role in enhancing colony formation.
What is the effective plasma concentration of chemo-drug?
5 answers
The effective plasma concentration of a chemo-drug is crucial for achieving maximum cytotoxic effects while minimizing toxicity. Maintaining plasma drug concentrations within a defined therapeutic range has been shown to improve efficacy and reduce toxicity for various groups of drugs, including antiasthmatic, antiarrhythmic, antibacterial, and antirheumatic drugs. For methotrexate, plasma levels need to be monitored, especially during high-dose therapy, to anticipate toxicity and the potential need for extended citrovorum factor rescue. Additionally, a correlation exists between toxicologic endpoints in animal systems and clinically achievable peak plasma concentrations (PPCs) in humans, aiding in selecting rational starting points for in vitro screening of new agents and in vitro doses for chemosensitivity assays.
What is the evolutionary significance of neocortex?
5 answers
The neocortex holds significant evolutionary importance as a distinguishing feature of mammals, enabling advanced cognitive abilities. Evolutionary changes in the neocortex, such as increased size, complexity, and the emergence of distinct cortical areas, have been crucial in the development of higher mental functions. Genetic variations, like the expression of TKTL1, have been linked to increased cortical neurogenesis in modern humans, potentially impacting cognitive disparities with archaic humans. Comparative transcriptome analyses between marsupials and eutherians have revealed molecular heterochronies in neocortical development, shedding light on gene expression variations that underlie neocortical evolution and diversification. The neocortex's role in sensory, motor, and cognitive abilities underscores its evolutionary significance across diverse mammalian lineages, with specific genetic changes contributing to the modification of key neurodevelopmental events.
Is Kdm5d a tumour suppressor in AML?
4 answers
Kdm5d is not specifically mentioned in the provided contexts. However, the Kdm5 family, including Kdm5b and Kdm5c, has been extensively discussed. Kdm5b has been identified as a tumor suppressor in acute myeloid leukemia (AML) by directly down-regulating AML stemness genes. On the other hand, Kdm5c has been highlighted as a tumor suppressor in AML, showing that reduced Kdm5c expression accelerates AML growth and is associated with a de-differentiation phenotype. These findings emphasize the tumor-suppressive roles of specific Kdm5 family members in AML. Further research may be needed to determine the specific role of Kdm5d in AML.
Why is the philadelphia chromosome only found in blood cells?
7 answers
The Philadelphia chromosome (Ph) is a specific genetic abnormality characterized by a reciprocal translocation between chromosome 9 and chromosome 22, leading to the formation of a truncated chromosome 22. This chromosomal aberration is the hallmark of chronic myeloid leukemia (CML) and is also found in various other leukemias, including acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic neutrophilic leukemia (CNL), and mixed phenotype acute leukemia (MPAL). The Ph chromosome results from aberrant ligation between two DNA double-strand breaks at the BCR gene on chromosome 9q34 and the ABL1 gene on chromosome 22q11, which are crucial initiation events for oncogenesis in Ph-positive leukemia. The presence of the Ph chromosome in blood cells is attributed to its origination in a pluripotential stem cell, affecting myeloid, megakaryocytic, and erythroid lineages. This suggests that the translocation disrupts genomic stability and impairs physiological signaling pathways in these cells, leading to their malignant transformation. The specific detection of the Ph chromosome in blood cells, rather than other cell types, is due to the nature of the affected stem cells that give rise to the blood cell lineages. Techniques such as karyotyping, Fluorescence in Situ Hybridization (FISH), and PCR are employed to diagnose the presence of the Ph chromosome, highlighting its detection primarily in blood cells. Moreover, the Ph chromosome's association with blood cell malignancies is further evidenced by its role in the pathogenesis of diseases like CML, where it is found in more than 90% of patients, and in ALL, where it significantly affects prognosis and treatment outcomes. The development of specific detection frameworks using image processing and deep learning techniques aims to improve the diagnosis of the Philadelphia chromosome, emphasizing its significance in blood cell disorders. Additionally, the Ph chromosome's impact on the clinical presentation and cellular biology of different phenotypes of Ph-positive leukemia underlines its critical role in the malignant transformation of blood cells. In summary, the Philadelphia chromosome is found exclusively in blood cells due to its origination from a mutation in pluripotential stem cells that differentiate into various blood cell lineages, leading to the development of specific leukemias where this genetic abnormality plays a pivotal role in disease progression and treatment response.
How a glutathione precursor impact infant cancer?
5 answers
The glutathione precursor, gamma-L-glutamyl-L-cysteine (γGlu-Cys), plays a crucial role in inhibiting oxidative injury, which is significant in cancer development. Glutathione (GSH), the primary antioxidant in humans, is closely linked to cancer progression and treatment outcomes. Studies have shown that the glutathione-S-transferase (GST) polymorphism, involved in detoxifying chemotherapeutic agents, impacts the outcome of childhood B-precursor acute lymphoblastic leukemia (ALL). Disruptions in GSH synthesis and changes in the GSH/GSSG ratio are common in malignant neoplasms, affecting tumor cell viability, drug resistance, and tumor progression. Therefore, by influencing oxidative stress and detoxification processes, a glutathione precursor like γGlu-Cys can potentially impact infant cancer by modulating cellular responses to oxidative damage and chemotherapeutic agents.
What is the role of IL-34 in the development and progression of cancer?
5 answers
IL-34 plays a significant role in cancer development and progression by influencing the tumor microenvironment and immune responses. It has been found to contribute to chemoresistance by modulating tumor-associated macrophages, promoting immunosuppression, and enhancing cancer cell survival. IL-34 can lead to adverse phenotypes in acute myeloid leukemia (AML) by accelerating disease progression, increasing leukemia stem cell levels, and promoting subcutaneous infiltration of AML cells. Additionally, IL-34 has been associated with resistance to immune checkpoint inhibitors (ICIs) in cancer treatment, suggesting that inhibiting IL-34 activity could potentially overcome ICI resistance and improve therapeutic outcomes. Furthermore, high IL-34 expression has been linked to poor prognosis in ovarian cancer, indicating its role in creating an immunosuppressive tumor microenvironment and conferring resistance to PARP inhibitor therapy.
Which cells coexpress cd31 and cd 169 ?
5 answers
CD31 and CD169 are coexpressed by specific cell types. CD31 is an adhesion molecule found in endothelial cells, leukocytes, and platelets, while CD169 is expressed by subpopulations of macrophages and dendritic cells. In the context of breast cancer, CD31 expression is acquired by cancer cells in ductal carcinoma in situ (DCIS) and correlates with tumor cell spreading within the ductal system. CD31 is also involved in the biological behavior of non-Hodgkin's lymphomas, showing specific patterns of expression in normal B-cell subpopulations and different NHL groups. Therefore, the coexpression of CD31 and CD169 is not explicitly mentioned in the provided contexts.
Which cells coexpress cd31, cd169 and cd27 ?
4 answers
CD31, CD169, and CD27 are coexpressed by specific cell populations. CD31 is an adhesion molecule found in various cells, including endothelial cells and leukocytes. CD27 is a marker commonly used to define human memory B cells. CD169, also known as Siglec-1, is expressed by subsets of macrophages and dendritic cells. While CD169 is not explicitly mentioned in the provided contexts, the information on CD31 and CD27 can be combined to infer that the coexpression of CD31, CD169, and CD27 is likely to occur in a specific subset of cells that exhibit characteristics of both endothelial cells and memory B cells. Further research may be needed to confirm the exact cell type that coexpresses these markers.